EP2869821A4 - COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS - Google Patents

COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS

Info

Publication number
EP2869821A4
EP2869821A4 EP13813787.2A EP13813787A EP2869821A4 EP 2869821 A4 EP2869821 A4 EP 2869821A4 EP 13813787 A EP13813787 A EP 13813787A EP 2869821 A4 EP2869821 A4 EP 2869821A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treating
methods
viral infections
inhibiting viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13813787.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2869821A2 (en
Inventor
Justice E Obi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRACELAND BIOTECHNOLOGY CATALYST, LLC
Original Assignee
GRACELAND BIOTECHNOLOGY Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/540,749 external-priority patent/US20140011837A1/en
Priority claimed from US13/687,273 external-priority patent/US20140011838A1/en
Priority claimed from US13/932,445 external-priority patent/US20140011839A1/en
Application filed by GRACELAND BIOTECHNOLOGY Inc filed Critical GRACELAND BIOTECHNOLOGY Inc
Publication of EP2869821A2 publication Critical patent/EP2869821A2/en
Publication of EP2869821A4 publication Critical patent/EP2869821A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
EP13813787.2A 2012-07-03 2013-07-02 COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS Withdrawn EP2869821A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13/540,749 US20140011837A1 (en) 2012-07-03 2012-07-03 Compositions and methods for treating warts associated with viral infections
US13/687,273 US20140011838A1 (en) 2012-07-03 2012-11-28 Compositions and methods for treating warts associated with viral infections
US13/932,445 US20140011839A1 (en) 2012-07-03 2013-07-01 Compositions and methods for treating and inhibiting viral infections
PCT/US2013/049046 WO2014008248A2 (en) 2012-07-03 2013-07-02 Compositions and methods for treating and inhibiting viral infections

Publications (2)

Publication Number Publication Date
EP2869821A2 EP2869821A2 (en) 2015-05-13
EP2869821A4 true EP2869821A4 (en) 2016-04-06

Family

ID=49882589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13813787.2A Withdrawn EP2869821A4 (en) 2012-07-03 2013-07-02 COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS

Country Status (4)

Country Link
EP (1) EP2869821A4 (zh)
CN (1) CN104703601A (zh)
CA (1) CA2927146A1 (zh)
WO (1) WO2014008248A2 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2544153B1 (es) 2014-02-24 2016-06-06 Ntd Labs, S.L. Uso de un hidrolizado de caseína como agente antiviral
CN104352495A (zh) * 2014-11-15 2015-02-18 广州凯普生物科技有限公司 一种治疗疣类疾病的药物
JP7176767B2 (ja) * 2017-04-13 2022-11-22 国立大学法人 鹿児島大学 新規なアモジアキン類似体およびその使用方法
KR20210044805A (ko) 2018-08-06 2021-04-23 닐슨 바이오사이언스, 아이엔씨. 사마귀의 치료
CN109288816B (zh) 2018-12-04 2019-11-22 广州凯普医药科技有限公司 一种氯喹凝胶及其制备方法和应用
CN110917196B (zh) * 2020-02-05 2020-06-05 广州康健医学科技有限公司 一种氯喹抑菌消毒液及其应用
CN112089841A (zh) * 2020-04-05 2020-12-18 徐静 用于治疗上皮组织病毒感染所致疾病的药物组合物
CN114848642A (zh) * 2022-07-07 2022-08-05 广州康健医学科技有限公司 磷酸氯喹在制备防治高危型hpv感染及宫颈癌前病变与宫颈癌的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1071409B1 (de) * 1998-04-14 2003-10-15 BioAgency AG Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
EP2581081A3 (en) * 2007-06-01 2013-07-31 The Trustees Of Princeton University Treatment of viral infections by modulation of host cell metabolic pathways

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JACOBS P H ET AL: "Effect of chloroquine anb placebo on warts", ARCHIVES OF DERMATOLOGY, AMERICAN MEDICAL ASSOCIATION, US, vol. 87, no. 1, 1 January 1963 (1963-01-01), pages 89 - 90, XP009188564, ISSN: 0003-987X *
MURPHY J C ET AL: "Chloroquine treatment of warts. A double-blind clinical study", ROCKY MOUNTAIN MEDICAL JOURNAL, COLORADO MEDICAL SOCIETY, DENVER, CO, US, vol. 62, no. 1, 1 January 1965 (1965-01-01), pages 25 - 26, XP009188565, ISSN: 0035-760X *
ZABEL H ET AL: "Sensitization to light during chloroquine diphosphate therapy", ZEITSCHRIFT FUER HAUT UND GESCHLECHTSKRANKHEITEN, GROSSE, BERLIN, DE, vol. 29, no. 7, 1 January 1960 (1960-01-01), pages 203 - 206, XP009188566, ISSN: 0044-2844 *

Also Published As

Publication number Publication date
CA2927146A1 (en) 2014-01-09
WO2014008248A3 (en) 2014-02-27
WO2014008248A2 (en) 2014-01-09
EP2869821A2 (en) 2015-05-13
CN104703601A (zh) 2015-06-10

Similar Documents

Publication Publication Date Title
HK1214521A1 (zh) 用於治療蛋白質病的組合物和方法
HK1209798A1 (zh) 用於治療癌症的組合物和方法
EP2836482A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP2890720A4 (en) COMPOSITIONS AND METHODS OF TREATING CANCER
HK1215170A1 (zh) 治療精神分裂症的方法和組合物
EP2817018A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
DK3292875T3 (en) Compositions and methods for treating diseases
EP2869821A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS
HK1206627A1 (zh) 抑制病毒聚合酶的組合物和方法
EP2802353A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
EP2912060A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING PATHOGEN INFECTION
HK1216854A1 (zh) 用於治療癌症的組合物和方法
EP2663327A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
EP2844258A4 (en) METHOD AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS
EP2878302A4 (en) COMPOSITION FOR PREVENTING OR TREATING OSTEOARTHRITIS
EP2931280A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING CNKSR1
HK1206238A1 (zh) 種預防和治療艾滋病的組合物及其製備方法
EP2981334A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY
EP2838903A4 (en) METHOD AND COMPOSITIONS FOR TREATING VIRUS INFECTIONS
HK1207561A1 (zh) 用於治療肝細胞癌的組合物和方法
HK1206594A1 (zh) 預防和治療病毒感染的材料和方法
EP2800763A4 (en) COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
EP2841102A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2822593A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
AU2012905097A0 (en) Agents and methods for inhibiting virus infection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150127

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20160304

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/20 20060101ALI20160229BHEP

Ipc: A61K 31/4706 20060101AFI20160229BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GRACELAND BIOTECHNOLOGY CATALYST, LLC

Owner name: OBI, JUSTICE E.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180201